Schellenberg Wittmer advised Geneva-based Vigama Capital on its license as manager of collective assets. By obtaining the licence in question, Vigama Capital unlocks the start of its own fund under the leadership of CIO Vincent
Tags :sx2
Niederer Kraft Frey (NKF) advised outpatient healthcare provider Affidea on the acquisition of Uroviva Group. Moreover, Advestra advised German Equity Partners IV, a fund managed by the independent German
MLL Legal’s patent team successfully represented the Swiss retailer COOP on appeal in EPO opposition proceedings against Katjes’ vegan chocolate patent at the European Patent Office, leading to full revoke of the patent in
American water technology specialist Xylem completed the acquisition of its long-standing Swiss distributor Heusser Water Solutions. Advestra advised Xylem, while Kellerhals Carrard represented the selling part. The context Headquartered in Washington and listed on the
As of February 2025, Cornelis “Kees”Van Ophem (pictured) joined KD Pharma Group’s management team as their new Global General Counsel & Secretary to the Board. Alongside these new responsibilities, he continues as Chairman of
On March 1st 2025, Swiss and international tax law specialist Laïla Rochat joined Schellenberg Wittmer as a partner, bolstering the firm’s Geneva-based Tax group. The profile A Swiss-certified tax-expert, attornery at-law Laïla Rochat
Swiss investment firm Nuavo completed its purchase of a majority stake Courgenay-based windows and doors manufacturer Domofen. Nexus Advocats advised the buyer throughout the operation, while Kellerhals Carrard represented the exiting shareholders. UBS took part
Kellerhals Carrard advised Swiss toy manufacturer Joker Entertainment on its sale to Cra-Z-Art. The context Kerzers-based Joker specialises in the development and manufacture of innovative toy compounds. The company’s portfolio includes the popular “Slimy”
Baker McKenzie advised Danish biotechnology company Novonesis on its acquisition of dsm-firmenich’s share in the Feed Enzyme Alliance. The context Novonesis is a global biotechnology company with headquarters in Bagsværd, just outside Copenaghen,
White & Case advised pharmaceutical multinational Takeda in connection with two distinct operations. The first matter sees Takeda involved as the seller of a pharmaceutical products portfolio, currently licensed to Hikma Pharmaceuticals. As a
